Inhalational anesthetic effects on rat cerebellar nitric oxide and cyclic guanosine monophosphate production

Anesthesiology

Volumn 86, Issue 3, 1997, Pages 689-698

  Rengasamy, Appavoo ^b   Pajewski, Thomas N ^b   Johns, Roger A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NONE

Author keywords

Anesthetics, inhalational: halothane; isoflurane; Cell signaling: nitric oxide; cyclic guanosine monophosphate; Neurotransmitters: N methyl D aspartate

Indexed keywords

CATALASE; CYCLIC GMP; GLYCINE; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; INHALATION ANESTHESIA; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ANESTHETICS, INHALATION; ANIMALS; ARGININE; CEREBELLUM; CITRULLINE; CYCLIC GMP; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; HALOTHANE; ISOFLURANE; N-METHYLASPARTATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; STIMULATION, CHEMICAL; TRITIUM;

EID: 0030973010     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199703000-00022     Document Type: Article

References (59)

1. Bredt DS, Snyder SH: Nitric oxide: A physiologic messenger molecule. Ann Rev Biochem 1994; 63:175-95
2. Garthwaite J, Boulton CL: Nitric oxide signaling in the central nervous system. Ann Rev Physiol 1995; 57:683-706
3. Bredt DS, Hwang PM, Snyder SH: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347:768-70
4. Richards CD, Smaje JC: Anaesthetics depress the sensitivity of cortical neurones to L-glutamate. Br J Pharmacol 1976; 58:347-57
5. MacIver MB, Roth SH: Inhalation anesthetics exhibit pathway-specific and differential actions on hippocampal synaptic responses in vitro. Br J Anaesth 1988; 60:680-91
6. Pearce RA, Stringer JL, Lothman EW: Effect of volatile anesthetics on synaptic transmission in the rat hippocampus. ANESTHESIOLOGY 1989; 71:591-8
7. Kant GJ, Muller TW, Lenox RH, Mayerhoff JL: In vivo effects of pentobarbital and halothane anesthesia on levels of adenosine 3′,5′ monophosphate and guanosine 3′,5′-monophosphate in rat brain regions and pituitary. Biochem Pharmacol 1980; 29:1891-6
8. Nahrwold ML, Lust WD, Passonneau JV: Halothane-induced alterations of cyclic nucleotide concentrations in three regions of the mouse nervous system. ANESTHESIOLOGY 1977; 47:423-7
9. Johns RA, Moscicki JC, DiFazio CA: Nitric oxide synthase inhibitor dose-dependently and reversibly reduces the threshold for halothane anesthesia. ANESTHESIOLOGY 1992; 77:779-84
10. G-L-arginine methyl ester, dose-dependently reduce the threshold for isoflurane anesthesia. ANESTHESIOLOGY 1996; 85:1111-9
11. Adachi T, Kurata J, Nako S-I, Murakawa M, Shichino T, Shirakami G, Shinomura T, Mori K: Nitric oxide synthase inhibitor does not reduce minimum alveolar anesthetic concentration of halothane in rats. Anesth Analg 1994; 78:1154-7
12. Scheller MS, Zornow MH, Fleischer JE, Shearman GT, Greber TF: The noncompetitive N-methyl-D-aspartate receptor antagonist, MK-801 profoundly reduces volatile anesthetic requirements in rabbits. Neuropharmacology 1989; 28:677-81
13. Daniell LC: The non-competitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics. Pharmacol Biochem Behavior 1990; 36:111-15
14. Rengasamy A, Spaeth J, Johns RA: Inhalational anesthetics inhibit glutamate stimulated cyclic GMP accumulation in rat cerebellum (abstract). ANESTHESIOLOGY 1993; 79:A580
15. Tobin JR, Martin LD, Breslow MJ, Traystman RJ: Selective anesthetic inhibition of brain nitric oxide synthase. ANESTHESIOLOGY 1994; 81:1264-9
16. Rengasamy A, Ravichandran LV, Reikersdorfer C, Johns RA: Inhalational anesthetics do not alter nitric oxide synthase activity. J Pharmacol Exp Ther 1995; 273:599-604
17. Tagliente TM: Halothane effects on rat brain nitric oxide synthase enzyme kinetics (abstract). ANESTHESIOLOGY 1994; 81:A806
18. Lischke V, Busse R, Hecker M: Inhalation anesthetics inhibit the release of endothelium-derived hyperpolarizing factor in the rabbit carotid artery. ANESTHESIOLOGY 1995; 83:574-82
19. Galley HF, Nelson LR, Webster NR: Anaesthetic agents decrease the activity of nitric oxide synthase from human polymorphonuclear leucocytes. Br J Anaesth 1995; 75:326-9
20. Terasako K, Nakamura K, Miyawaki 1, Toda H, Kakuyama M, Mori K: Inhibitory effects of anesthetics on cyclic guanosine monophosphate (cGMP) accumulation in rat cerebellar slices. Anesth Analg 1994; 79:921-6
21. Johns RA, Tichotsky A, Muro M, Spaeth JP, Le Cras TD, Rengasamy A: Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation. ANESTHESIOLOGY 1995; 83:823-34
22. Biaise G, To Q, Parent M, Lagarde B, Asenjo F, Sauve R: Does halothane interfere with the release, action, or stability of endothelium-derived relaxing factor/nitric oxide? ANESTHESIOLOGY 1994; 80:417-26
23. Zuo Z, Johns RA: Halothane, enflurane and isoflurane do not affect the basal or agonist-stimulated activity of partially isolated soluble and particulate guanylyl cyclases of rat brain. ANESTHESIOLOGY 1995; 83:395-404
24. Johns RA: Endothelium, anesthetics and vascular control. ANESTHESIOLOGY 1993; 79:1381-91
25. Bredt DS, Snyder SH: Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989; 86:9030-3
26. Johns RA, Peach MJ: Parabromphenacyl bromide inhibits endothelium-dependent arterial relaxation and cyclic GMP accumulation by effects produced exclusively in the smooth muscle. J Pharmacol Exp Ther 1988; 244:859-65
27. Martin DC, Plagenhoef M, Abraham J, Dennison RL, Aronstam RS: Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors. Biochem Pharmacol 1995; 49:809-17
28. Daniell LC, Harris A: Neuronal intracellular calcium concentrations are altered by anesthetics: Relationship to membrane fluidization. J Pharmacol Exp Ther 1988; 245:1-7
29. Mody I, Tanelian DL, Maclver MB: Halothane enhances tonic neuronal inhibition by elevating intracellular calcium. Brain Res 1991; 538:319-23
30. Puil E, El-Beheiry H, Baimbridge KG: Anesthetic effects on glutamate-stimulated increase in intraneuronal calcium. J Pharmacol Exp Ther 1990; 255:955-61
31. Takenoshita M, Steinback JH: Halothane blocks low-voltage-activated calcium current in rate sensory neurons. J Neurosci 1991; 11:1404-12
32. Bickler PE, Buck LT, Hansen BM: Effects of isoflurane and hypothermia on glutamate receptor-mediated calcium influx in brain slices. ANESTHESIOLOGY 1994; 81:1461-9
33. 2+ transients and glutamate release in isolated cerebral synaptosomes. ANESTHESIOLOGY 1995; 83:593-603
34. Gonzales JM, Loeb AL, Reichard PS: Isoflurane and enflurane enhance glutamatergic-agonist stimulated nitric oxide production in primary cultures of cerebral neurons (abstract). ANESTHESIOLOGY 1995; 83:A693
35. Nussler AK, Billiar TR, Liu Z-Z, Morris SM Jr: Coinduction of nitric oxide synthase and argininosuccinate synthetase in a murine macrophage cell line. Implications for regulation of nitric oxide production. J Biol Chem 1994; 269:1257-61
36. Zuo Z, De Vente J, Johns RA: Halothane and isoflurane dose-dependently inhibit the cyclic GMP increase caused by N-methyl-D-aspartate in rat cerebellum: Novel localization and quantitation by in vitro autoradiography. Neuroscience 1996; 74:1069-75
37. Nagelhout JJ, Ferdinand RT, Beuthin FC: Effect of halothane on brain 2′3′-cyclic nucleotide 3′-phosphodiesterase during neurodevelopment in the rat. Res Commun Chem Pathol Pharmacol 1986; 53:261-4
38. Ewart RB, Rusy BF, Bradford MW: Enflurane and adenosine 3′,5′-cyclic monophosphate metabolism in pancreatic islets. Anesth Analg 1985; 64:18-22
39. Volpi M, Sha'afi RI, Epstein PM, Andrenyak DM, Feinstein MB: Local anesthetics, mepacrine, and propranolol are antagonists of calmodulin. Proc Nat Acad Sci USA 1981; 78:795-9
40. Rudnick S, Stevenson GW, Hall SC, Espinoza-Delgado I, Stevenson HC, Longo DL: Halothane potentiates antitumor activity of gamma-interferon and mimics calmodulin-blocking agents. ANESTHESIOLOGY 1991; 74:115-19
41. Nakamura K, Terasako K, Toda H, Miyawaki I, Kakuyama M, Nishiwada M, Hatano Y, Mon K: Mechanisms of inhibition of endothelium-dependent relaxation by halothane, isoflurane and sevoflurane. Can J Anesth 1994; 41:340-6
42. Rengasamy A, Johns RA: Characterization of endothelium-derived relaxing factor/nitric oxide synthase from bovine cerebellum and mechanism of modulation by low and high oxygen tensions. J Pharmacol Exp Ther 1991; 259:310-16
43. Shayevitz JR, Varani J, Ward PA, Knight PR: Halothane and isoflurane increase pulmonary artery endothelial cell sensitivity to oxidant-mediated injury. ANESTHESIOLOGY 1991; 74:1067-77
44. Yoshida K-I, Okabe E: Selective impairment of endothelium-dependent relaxation by sevoflurane: Oxygen free radicals participation. ANESTHESIOLOGY 1992; 76:440-7
45. Hart JL, Jing M, Bina S, Freas W, Van Dyke RA, Muldoon SM: Effects of halothane on EDRF/cGMP-mediated vascular smooth muscle relaxations. ANESTHESIOLOGY 1993; 79:323-31
46. Suria A, Resheed F: Evidence for involvement of amino acid neurotransmitters in anesthesia and naloxone induced reversal of respiratory paralysis. Life Sci 1994; 54:2021-33
47. Gerdes C, Richter A, Annies R, Loscher W: Increase of serotonin in plasma during onset of halothane-induced malignant hypothermia in pigs. Eur J Pharmacol 1992; 220:91-4
48. Maura G, Guadagnin A, Raiteri M: Low nanomolar serotonin inhibits the glutamate receptor/nitric oxide/cyclic GMP pathway in slices from adult rat cerebellum. Neuroscience 1995; 68:455-63
49. W-nitro-L-arginine methyl ester during delayed hypofusion in cats. Am J Physiol 1994; 267:H174-H181
50. Wang Q, Pelligrino DA, Baughman VL, Koenig HM, Albrecht RF: The role of neuronal nitric oxide synthase in regulation of cerebral blood flow in normocapnia and hypercapnia in rats. J Cereb Blood Flow Metab 1995; 15:774-8
51. W-nitro-L-arginine methyl ester prevents cerebral hyperemia by inhaled anesthetics in dogs. Anesth Analg 1993; 77:891-7
52. Zhang F, Iadecola C: Reduction of focal cerebral ischemic damage by delayed treatment with nitric oxide donors. J Cereb Blood Flow Metab 1994; 14:574-80
53. Shen W, Xu X, Ochoa M, Zhao G, Wolin MS, Hintze TH: Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res 1994; 75:1086-95
54. Wei HM, Chi OZ, Liu X, Sinha AK, Weiss HR: Nitric oxide synthase inhibition alters cerebral blood flow and oxygen balance in focal cerebral ischemia in rats. Stroke 1994; 25:445-50
55. Sakabe T, Maekawa W, Fijii S, Ishikawa T, Tateishi A, Takeshita H: Cerebral circulation and metabolism during enflurane anesthesia in humans. ANESTHESIOLOGY 1983; 59:532-6
56. Baughman VL, Hoffman WE, Thomas C, Miletich DJ, Albrecht RF: Comparison of methohexital and isoflurane on neurologic outcome and histopathology following incomplete ischemia in rats. ANESTHESIOLOGY 1990; 72:85-94
57. Brussel T, Fitch W, Brodner G, Arendt I, Van Aken H: Effects of halothane in low concentrations on cerebral blood flow, cerebral metabolism, and cerebrovascular autoregulation in the baboon. Anesth Analg 1991; 73:758-64
58. McPherson RW, Kirsch JR, Tobin JR, Ghaly RF, Traystman RJ: Cerebral blood flow in primates is increased by isoflurane over time and is decreased by nitric oxide synthase inhibition. ANESTHESIOLOGY 1994; 80:1320-7
59. Todd MM, Wu B, Warner DS, Maktabi M: The dose-related effects of nitric oxide synthase inhibition on cerebral blood flow during isoflurane and pentobarbital anesthesia. ANESTHESIOLOGY 1994; 80:1128-36